Related Experiment Video
Updated: Jul 1, 2025

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Breastfeeding is associated with enhanced intestinal gluconeogenesis in infants
Duan Ni1,2,3, Jian Tan1,4, Laurence Macia1,4,5
1Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
Insights
Breastfeeding enhances intestinal gluconeogenesis in infants, a key mechanism for metabolic health. This finding in human infants is consistent with observations in other mammals, highlighting its biological importance.
Area of Science:
- Pediatrics
- Metabolic Health
- Developmental Biology
Background:
- Breastfeeding (BF) offers significant metabolic advantages to infants, potentially reducing risks of metabolic syndrome, obesity, and diabetes later in life.
- The precise biological mechanisms underlying these benefits remain incompletely understood.
- Investigating the impact of breastfeeding on infant metabolic organs is crucial for elucidating these mechanisms.
Purpose of the Study:
- To investigate the effects of breastfeeding on the metabolic organs of infants.
- To explore the molecular pathways through which breastfeeding influences infant metabolism.
- To identify potential mechanisms linking breastfeeding to long-term metabolic health.
Main Methods:
- A comprehensive review of existing literature on breastfeeding's influence on offspring metabolic organs in both animal models and human studies.
- Analysis of a microarray dataset examining intestinal gene expression in infants fed breast milk versus formula milk.
Main Results:
- Reanalysis of microarray data revealed that breastfeeding is associated with enhanced intestinal gluconeogenesis in infants.
- This finding in human infants mirrors observations in other mammalian species, where breastfeeding has also been linked to increased gluconeogenesis.
Conclusions:
- Breastfeeding promotes enhanced intestinal gluconeogenesis in infants, likely contributing to its metabolic benefits.
- This mechanism may play a role in fine-tuning metabolic homeostasis, supporting infant health.
- The conservation of this effect across species suggests significant biological importance.
Background:
Breastfeeding (BF) confers metabolic benefits to infants, including reducing risks of metabolic syndrome such as obesity and diabetes later in life. However, the underlying mechanism is not yet fully understood. Hence, we aim to investigate the impacts of BF on the metabolic organs of infants.
Methods:
Previous literatures directly studying the influences of BF on offspring's metabolic organs in both animal models and humans were comprehensively reviewed. A microarray dataset of intestinal gene expression comparing infants fed on breastmilk versus formula milk was analyzed.
Results:
Reanalysis of microarray data showed that BF is associated with enhanced intestinal gluconeogenesis in infants. This resembles observations in other mammalian species showing that BF was also linked to increased gluconeogenesis.
Conclusions:
BF is associated with enhanced intestinal gluconeogenesis in infants, which may underpin its metabolic advantages through finetuning metabolic homeostasis. This observation seems to be conserved across species, hinting its biological significance.
More Related Videos
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucose Absorption Into the Small Intestine
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin Secretory Vesicles

